Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
17.15
Dollar change
-0.22
Percentage change
-1.27
%
IndexRUT P/E27.34 EPS (ttm)0.63 Insider Own41.61% Shs Outstand33.44M Perf Week21.37%
Market Cap636.78M Forward P/E- EPS next Y-3.52 Insider Trans0.08% Shs Float21.68M Perf Month10.15%
Income23.48M PEG- EPS next Q0.36 Inst Own42.60% Short Float8.02% Perf Quarter29.34%
Sales162.87M P/S3.91 EPS this Y-73.94% Inst Trans-0.75% Short Ratio18.93 Perf Half Y4.07%
Book/sh8.02 P/B2.14 EPS next Y-911.29% ROA4.76% Short Interest1.74M Perf Year8.68%
Cash/sh8.82 P/C1.94 EPS next 5Y- ROE9.41% 52W Range10.75 - 18.44 Perf YTD13.65%
Dividend Est.- P/FCF- EPS past 5Y-5.52% ROI7.17% 52W High-7.00% Beta-0.22
Dividend TTM- Quick Ratio2.38 Sales past 5Y0.00% Gross Margin98.05% 52W Low59.53% ATR (14)0.83
Dividend Ex-Date- Current Ratio2.38 EPS Y/Y TTM127.57% Oper. Margin14.57% RSI (14)67.06 Volatility7.40% 5.07%
Employees159 Debt/Eq0.25 Sales Y/Y TTM544.79% Profit Margin14.42% Recom1.00 Target Price21.50
Option/ShortYes / Yes LT Debt/Eq0.22 EPS Q/Q427.55% Payout- Rel Volume2.07 Prev Close17.37
Sales Surprise294.69% EPS Surprise214.48% Sales Q/Q134.05% EarningsMay 07 BMO Avg Volume91.87K Price17.15
SMA2014.57% SMA5015.27% SMA20018.72% Trades Volume190,486 Change-1.27%
Date Action Analyst Rating Change Price Target Change
Jan-05-24Initiated Oppenheimer Outperform $22
Apr-03-23Initiated H.C. Wainwright Buy $25
Jul-12-24 09:33AM
Jun-24-24 07:15AM
06:00AM
Jun-03-24 07:00AM
May-21-24 09:55AM
05:32PM Loading…
May-20-24 05:32PM
May-16-24 07:02PM
04:35PM
07:00AM
May-07-24 01:53PM
07:00AM
Apr-10-24 03:29PM
Apr-04-24 02:00PM
Mar-27-24 01:27AM
Mar-15-24 05:31AM
07:00AM Loading…
Mar-13-24 07:00AM
Feb-07-24 07:00AM
Jan-29-24 08:14AM
Jan-03-24 07:00AM
Dec-28-23 07:01AM
Nov-23-23 11:47AM
Nov-22-23 07:00AM
Nov-07-23 08:25AM
08:06AM
07:00AM
Oct-12-23 07:00AM
Sep-21-23 07:00AM
Sep-16-23 01:01AM
Sep-07-23 07:00AM
Aug-29-23 07:00AM
07:00AM Loading…
Aug-10-23 07:00AM
Aug-08-23 08:40AM
07:00AM
Aug-04-23 06:36AM
Aug-01-23 07:00AM
Jul-21-23 06:43AM
Jun-06-23 07:00AM
May-15-23 06:03AM
May-13-23 08:03AM
May-10-23 07:00AM
Apr-30-23 10:26AM
Apr-04-23 07:00AM
Mar-29-23 07:00AM
Mar-08-23 06:02AM
Mar-06-23 07:00AM
Feb-27-23 07:00AM
Feb-09-23 07:00AM
Jan-09-23 07:00AM
Dec-22-22 08:07AM
Dec-20-22 10:03AM
Dec-19-22 04:30PM
Dec-14-22 10:24AM
Dec-09-22 01:41PM
Dec-08-22 04:12PM
10:58AM
08:24AM
07:00AM
Nov-22-22 07:00AM
Nov-07-22 07:00AM
Aug-30-22 07:00AM
Aug-11-22 07:00AM
Aug-04-22 07:00AM
Jul-19-22 07:00AM
Jul-14-22 10:47AM
Jul-06-22 07:00AM
Jun-01-22 07:00AM
May-12-22 07:00AM
May-11-22 09:30AM
May-10-22 07:00AM
Mar-15-22 07:00AM
Feb-23-22 08:00AM
Feb-04-22 01:27PM
Feb-03-22 09:38AM
Jan-05-22 08:00AM
Dec-17-21 08:00AM
Dec-09-21 07:00AM
Nov-18-21 08:00AM
Nov-05-21 08:32AM
Nov-02-21 04:26PM
Oct-28-21 10:21PM
Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WENTWORTH KORY JAMESChief Financial OfficerJul 08 '24Sale14.951,75826,28281,412Jul 10 04:34 PM
Doshi DipalCEOJun 13 '24Sale16.171,00016,174336,375Jun 14 04:32 PM
KIM PETER SDirectorJun 03 '24Option Exercise6.0611,91872,223104,330Jun 05 04:31 PM
Sethuraman NatarajanChief Scientific OfficerMay 20 '24Sale15.199,675146,944190,052May 20 05:26 PM
Sethuraman NatarajanChief Scientific OfficerMay 17 '24Sale15.148,305125,751199,727May 20 05:26 PM
Doshi DipalCEOMay 17 '24Sale15.111,20018,129337,375May 20 05:21 PM
Doshi DipalCEOMay 16 '24Sale15.001,80027,000338,575May 20 05:21 PM
Sethuraman NatarajanChief Scientific OfficerMay 16 '24Sale15.001,00015,000208,032May 20 05:26 PM
KIM PETER SDirectorMay 14 '24Buy14.5925,000364,67292,412May 16 04:33 PM
KIM PETER SDirectorMay 09 '24Buy14.252,20031,34167,412May 10 04:35 PM
KIM PETER SDirectorMay 08 '24Buy14.042,27631,96565,212May 10 04:35 PM
KIM PETER SDirectorApr 08 '24Buy13.572,60035,29062,936Apr 10 04:35 PM
KIM PETER SDirectorMar 28 '24Buy13.751,51220,79460,336Apr 01 04:31 PM
KIM PETER SDirectorMar 26 '24Buy13.642,75037,50958,824Mar 26 05:57 PM
KIM PETER SDirectorMar 25 '24Buy13.363,18042,47256,074Mar 26 05:57 PM
KIM PETER SDirectorMar 22 '24Buy13.763,11842,90152,894Mar 26 05:57 PM
KIM PETER SDirectorMar 21 '24Buy13.247049,31849,776Mar 21 04:31 PM
KIM PETER SDirectorMar 20 '24Buy12.661,12814,28149,072Mar 21 04:31 PM
KIM PETER SDirectorMar 19 '24Buy12.6690011,39747,944Mar 21 04:31 PM
WENTWORTH KORY JAMESChief Financial OfficerMar 15 '24Option Exercise2.109,00018,90083,170Mar 19 04:33 PM
WENTWORTH KORY JAMESChief Financial OfficerMar 06 '24Sale12.314,08650,28574,170Mar 08 04:36 PM
Dowden Nathan JPresident & COOMar 06 '24Sale12.321,82622,499137,204Mar 08 04:34 PM
Doshi DipalCEOFeb 15 '24Sale15.001,00015,000243,279Feb 20 04:37 PM
Doshi DipalCEOJan 16 '24Sale15.991,00015,990244,279Jan 18 04:32 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 26 '23Option Exercise2.109419749,665Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 26 '23Sale16.67941,56749,571Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 22 '23Option Exercise2.1010,20621,43359,777Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 22 '23Sale15.6910,206160,12449,571Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 21 '23Option Exercise2.102,2004,62051,771Dec 26 04:35 PM
WENTWORTH KORY JAMESChief Financial OfficerDec 21 '23Sale15.072,20033,15549,571Dec 26 04:35 PM
Doshi DipalPresident and CEODec 20 '23Sale15.001,00015,000245,279Dec 22 04:38 PM
Doshi DipalPresident and CEONov 13 '23Sale16.231,00016,230246,279Nov 13 04:35 PM
Doshi DipalPresident and CEOOct 17 '23Sale15.001,00015,000247,279Oct 19 05:27 PM
Doshi DipalPresident and CEOSep 13 '23Sale15.001,00015,000248,279Sep 15 04:21 PM
Dowden Nathan JChief Operating OfficerSep 06 '23Sale13.4797213,08948,168Sep 06 05:07 PM
WENTWORTH KORY JAMESChief Financial OfficerSep 06 '23Sale13.4895012,80649,571Sep 06 05:11 PM
KREHER NERISSAChief Medical OfficerSep 06 '23Sale13.4889212,02240,037Sep 06 05:08 PM
Doshi DipalPresident and CEOAug 14 '23Sale15.671,00015,671201,069Aug 16 04:32 PM
KREHER NERISSAChief Medical OfficerAug 04 '23Option Exercise2.106,89814,48634,028Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 04 '23Sale14.146,89897,52127,130Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 03 '23Option Exercise2.109,46419,87436,594Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 03 '23Sale14.749,464139,53027,130Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 02 '23Option Exercise2.1010,34821,73137,478Aug 04 04:50 PM
KREHER NERISSAChief Medical OfficerAug 02 '23Sale15.1910,348157,16827,130Aug 04 04:50 PM